Directorate Change and Notice of Results

Hipgnosis Songs Fund Limited
10 July 2023
 

LEI: 213800XJIPNDVKXMOC11

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Appointment of Non-Executive Director and Notice of Results

10 July 2023

The Board of Hipgnosis, the first UK listed investment company offering investors a pure-play exposure to songs and associated musical intellectual property rights, is pleased to announce the appointment of Cindy Rampersaud as an independent non-executive director of the Company with effect from 1 August 2023.

Ms Rampersaud is a Chartered Accountant with considerable experience across a range of organisations within the education, entertainment, media and charitable sectors. She previously held senior executive roles at Virgin, Warner Brothers, EMI, the Department for Education and, most recently, Pearson, where she headed up the global BTEC and apprenticeships business.

Ms Rampersaud is currently a non-executive director of Sage Housing and an advisory board member and chair of audit & risk at the UK Health Security Agency. She is also a trustee of both The London Film School and the Consumers' Association (the publishers of Which?).

Ms Rampersaud will be appointed as a member of the following Board committees with effect from her appointment to the Board:

-      Audit and Risk Management Committee;

-      Environmental, Social and Governance Committee;

-      Management Engagement Committee;

-      Nomination Committee;

-      Portfolio Committee; and

-      Remuneration Committee.

Shareholders will have the opportunity to vote on Ms Rampersaud's appointment as a new director at the AGM later this year. Ms Rampersaud does not currently own any ordinary shares in the Company.

There are no further details to disclose under paragraphs 9.6.13 R (1) to (6) of the Listing Rules in respect of Cindy Rampersaud.

Andrew Sutch, Chairman of the Company, said:

"I am delighted that Cindy has agreed to join the Board of Hipgnosis. Cindy has an impressive background in a variety of complex finance and investment roles as well as extensive experience serving on boards across a range of industries. All of this will enhance the complementary mix of skills and expertise of our existing Directors."

Merck Mercuriadis, CEO and founder of Hipgnosis Song Management and founder of Hipgnosis Songs Fund said:

"We welcome Cindy to the Hipgnosis family. Her wealth of experience in both music and the wider market will be the perfect complement to Andrew, Sylvia, Paul, Simon and Andrew, who have a combined almost 24 years experience on our board. We very much look forward to working with her."

Notice of Results

The Company will be announcing its full year results for the year ending 31 March 2023 on Thursday 13 July.  The Investment Adviser will present a webinar for analysts and investors at 1000 BST. 

Registration for the live webcast is available at:

https://www.lsegissuerservices.com/spark/HipgnosisSongsFundLtd/events/17896f4e-5aa3-44ce-8303-1d15f263d1af 

A video recording of the event will be made available on the Company's website (www.hipgnosissongs.com) after the event. 

For more information:

For further information please contact:

 

Hipgnosis Song Management

Merck Mercuriadis

Chris Helm

Giles Croot (Media)

Rufina Pavry (Investors)

 

 

 

 

 

+44 (0)20 4542 1511

+44 (0)20 4542 1530

Singer Capital Markets - Joint Corporate Broker

James Moat / James Maxwell / Alex Emslie (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

 

+44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

 

+44 (0)20 7742 4000

RBC Capital Markets - Joint Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

Lisa Tugwell / Anastasia Mikhailova (Sales)

 

+44 (0)20 7635 4000

Ocorian - Company Secretary & Administrator

Lorna Zimny

 

+44 (0) 28 9693 0222

Headland Consultancy

Susanna Voyle / Del Jones / Charlie Twigg

 

+44 (0) 20 3805 4822

The Outside Organisation

Alan Edwards / Nick Caley

 

+44 (0)7711 081 843

All US music publicity enquiries

Fran Defeo

 

+1 917 767 5255

 



Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In March 2020 the Company became a constituent of the FTSE 250 Index. The Company is recognised as an investment trust under applicable HMRC regulations.



 

About Hipgnosis Song Management Limited

 

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings